Table 2 General findings and follow up of the WDT-UMP lesion group
From: Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential
S.No | Age at presentation | Sex | Presenting complaints | Diagnosis since | Prognosis |
|---|---|---|---|---|---|
1 | 63 years | M | Nodular goitre | 10 years | No recurrence |
2 | 56 years | F | Nodular goitre | 5 years | No recurrence |
3 | 55 years | F | Nodular goitre | 5 years | No recurrence |
4 | 57 years | F | Nodular goitre | 10 years | No recurrence |
5 | 50 years | F | Nodule with dysphonia | 3 years | No recurrence |
6 | 50 years | F | Multinodular goitre | 13 years | No recurrence |
7 | 39 years | F | Multinodular goitre | 3 years | No recurrence |
8 | 37 years | M | Mutinodular goitre | 5 years | No recurrence |
9 | 36 years | F | Nodule with hepatitis C | 9 years | No recurrence |
10 | 34 years | F | Multinodular goitre | 13 years | Lost to follow up |
11 | 27 years | F | Nodular goitre | 11 years | No recurrence |
12 | 17 years | F | Nodular goitre | 7 years | No recurrence |
13 | 13 years | F | Nodular goitre | 6 years | No recurrence |